Recordati's Rare Disease Focus Unveiled at ASH 2026
Pioneering Steps in Rare Hematologic Diseases When it comes down to tackling rare diseases, Recordati's taking concrete steps. This year's American Society of Hematology (ASH) Annual Meeting in New Orleans is their stage, where they're laying out fresh data on two unique fronts: cold agglutinin disease (CAD) and idiopathic multicentric Castleman disease (iMCD). They're...
Continue Reading